Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
(R)-Duloxetine is a serotonin and norepinephrine reuptake inhibitor (SNRI) and voltage-gated sodium channel inhibitor.1,2 It selectively inhibits neurotransmitter reuptake in HEK cells expressing the serotonin transporter (SERT) or norepinephrine transporter (NET; IC50s = 2.6 and 13.2 nM, respectively) over cells expressing the dopamine transporter (DAT; IC50 = 809 nM).1 It also selectively inhibits inactivated over resting voltage-gated sodium channels in GH3 rat pituitary cells (IC50s = 5.82 and 33.8 µM, respectively).2 Subcutaneous administration of (R)-duloxetine (2 mg) reduces allodynia and hyperalgesia in a rat model of postoperative pain induced by skin incision plus extension (SIE).
WARNING This product is not for human or veterinary use.
1. Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-
2. R-